Price
$1.11-5.13%Social Signal Score
Analyst Ratings
6 analystsRevenue
$4.16MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Erez I. Meltzer
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 197
- Beta
- 1.25
- Country
- IL
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -9.70
Financials
Revenue
$4.16M+218.7%Net Income
$-55.49MEBITDA
$-52.66MFree Cash Flow
$-12.58MEPS (diluted)
$-0.79Shares Outstanding (diluted)
69.93M+198.2%Operating Expenses
$12.05MCash & Debt
$31.02MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $13.02M | $-75.02M | $-1.16 |
| 2024 | $11.28M | $-53.52M | $-0.91 |
| 2023 | $9.90M | $-60.78M | $-1.08 |
| 2022 | $8.58M | $-105.24M | $-2.01 |
| 2021 | $1.30M | $-61.80M | $-1.28 |
| 2020 | $0.00 | $-43.50M | $-1.22 |
| 2019 | $0.00 | $-22.55M | $-0.49 |
| 2018 | $0.00 | $-1.91M | $-0.06 |
Valuation
NNOXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
150+400.00%Social Signal Score
Mentions (5)
- Newsseekingalpha.com·26d ago·Positive
Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·27d ago·Negative
Nano-X Imaging Q2 Earnings Call Highlights Nano-X Imaging NASDAQ: NNOX reported second-quarter 2026 revenue growth driven by its teleradiology, health IT and AI businesses, while recording a substantial non-cash impairment charge and outlining cost-reduction actions intended to extend its cash runway.
View source ↗ - Newsglobenewswire.com·27d ago·Neutral
Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates PETACH TIKVA, Israel, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2026, and provided a business update.
View source ↗ - Newsglobenewswire.com·41d ago·Positive
…ond Quarter 2026 Financial Results on September 9, 2026 PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2026, before market open on Monday, September, 9, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Guy Nathanzon, Chief Financial Officer, will host a conference call t…
View source ↗ - Newsglobenewswire.com·49d ago·Negative
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“ Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced its subsidiary, Nanox AI Ltd.
View source ↗
Earnings
Thu, Nov 19(in 6 weeks)
Consensus estimate $-0.15 per share
Typical surprise -31.4% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Sep 9$-0.79 vs $-0.16miss
- Thu, Jun 25$-0.20 vs $-0.14miss
- Mon, Apr 20$-0.50 vs $-0.23miss
- Thu, Nov 20$-0.21 vs $-0.21beat
- Tue, Aug 12$-0.23 vs $-0.17miss
- Thu, May 22$-0.21 vs $-0.19miss
Estimates and results for NNOX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NNOX officers and directors.
- Bought
- $183k
- Sold
- $1k
10 trades
2 trades
- Meltzer Erezbought
- Suesskind Dan Sbought
- Suesskind Dan Sbought
- Meltzer Erezbought
- Meltzer Erezbought
- Kainan Nogabought
- Suesskind Dan Sbought
- Suesskind Dan Sbought
56 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NNOX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.